Lesley Ann Saketkoo

Summary

Publications

  1. ncbi request reprint Impact of biologic agents on infectious diseases
    Lesley Ann Saketkoo
    Division of Rheumatology, Ochsner Clinic Foundation, New Orleans, LA 70115, USA
    Infect Dis Clin North Am 20:931-61, viii. 2006
  2. doi request reprint Developing disease activity and response criteria in connective tissue disease-related interstitial lung disease
    Lesley Ann Saketkoo
    Section of Rheumatology, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA
    J Rheumatol 38:1514-8. 2011
  3. doi request reprint Axial gouty arthropathy
    Lesley Ann Saketkoo
    Section of Rheumatology, Department of Internal Medicine, Louisiana State University Health Sciences Center, 820 Napoleon Avenue, Suite 890, New Orleans, LA 70115, USA
    Am J Med Sci 338:140-6. 2009
  4. doi request reprint Experience of mycophenolate mofetil in 10 patients with autoimmune-related interstitial lung disease demonstrates promising effects
    Lesley Ann Saketkoo
    Section of Rheumatology, Department of Internal Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70115, USA
    Am J Med Sci 337:329-35. 2009
  5. doi request reprint Revisiting Jaccoud arthropathy as an ultrasound diagnosed erosive arthropathy in systemic lupus erythematosus
    Lesley Ann Saketkoo
    Section of Rheumatology, Department of Internal Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA
    J Clin Rheumatol 13:322-7. 2007
  6. ncbi request reprint Normal bowel function restored after oxygen therapy in systemic sclerosis and colonic inertia
    Lesley Ann Saketkoo
    Section of Rheumatology, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA
    J Rheumatol 34:1777-8. 2007
  7. pmc Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials
    Lesley Ann Saketkoo
    Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA
    Thorax 69:428-36. 2014
  8. pmc Outcome Measures for Clinical Trials in Interstitial Lung Diseases
    Matthew R Lammi
    Louisiana State University Health Sciences Center, New Orleans, New Orleans, LA, USA New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center New Orleans, LA, USA
    Curr Respir Med Rev 11:163-174. 2015
  9. doi request reprint Biologic therapies in the treatment of sarcoidosis
    Lesley Ann Saketkoo
    a New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, University Medical Center Comprehensive Pulmonary Hypertension Center, Tulane University Lung Center, New Orleans, LA, USA
    Expert Rev Clin Immunol 12:817-25. 2016
  10. pmc Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases
    Lesley Ann Saketkoo
    From the Louisiana State University LSU Scleroderma and Sarcoidosis Patient Care and Research Center, LSU Interstitial Lung Disease Program, LSU Health Sciences Center, New Orleans, Louisiana, USA University of Toronto, Interstitial Lung Disease Program, University Health Network Mount Sinai Hospital, Toronto, Ontario Faculty of Social Work, University of Manitoba, Winnipeg, Manitoba, Canada Louisiana Office of Public Health, Department of Health and Human Services, New Orleans, Louisiana Division of Rheumatology Internal Medicine, University of Michigan, Ann Arbor, Michigan Division of Immunology, Stanford University, Palo Alto, California and Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA
    J Rheumatol 41:792-8. 2014

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Impact of biologic agents on infectious diseases
    Lesley Ann Saketkoo
    Division of Rheumatology, Ochsner Clinic Foundation, New Orleans, LA 70115, USA
    Infect Dis Clin North Am 20:931-61, viii. 2006
    ..Maintenance of a high index of suspicion is imperative for the prevention and appropriate treatment of serious life-threatening infections in these patients...
  2. doi request reprint Developing disease activity and response criteria in connective tissue disease-related interstitial lung disease
    Lesley Ann Saketkoo
    Section of Rheumatology, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA
    J Rheumatol 38:1514-8. 2011
    ..We summarize the design of the studies we are conducting and progress leading to the OMERACT 10 and 2010 EULAR meetings...
  3. doi request reprint Axial gouty arthropathy
    Lesley Ann Saketkoo
    Section of Rheumatology, Department of Internal Medicine, Louisiana State University Health Sciences Center, 820 Napoleon Avenue, Suite 890, New Orleans, LA 70115, USA
    Am J Med Sci 338:140-6. 2009
    ..The pervasiveness of cardiovascular disease and chronic back pain warrants a closer look into a possible occult contributor to the prevalence of chronic back pain: gout...
  4. doi request reprint Experience of mycophenolate mofetil in 10 patients with autoimmune-related interstitial lung disease demonstrates promising effects
    Lesley Ann Saketkoo
    Section of Rheumatology, Department of Internal Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70115, USA
    Am J Med Sci 337:329-35. 2009
    ..Cyclophosphamide (CYC) is extensively used in SSc ILD with moderate initial response but a poor long-term outcome, and is associated with significant toxicity...
  5. doi request reprint Revisiting Jaccoud arthropathy as an ultrasound diagnosed erosive arthropathy in systemic lupus erythematosus
    Lesley Ann Saketkoo
    Section of Rheumatology, Department of Internal Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA
    J Clin Rheumatol 13:322-7. 2007
    ....
  6. ncbi request reprint Normal bowel function restored after oxygen therapy in systemic sclerosis and colonic inertia
    Lesley Ann Saketkoo
    Section of Rheumatology, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA
    J Rheumatol 34:1777-8. 2007
    ..As a result of respiratory decompensation, she was placed on oxygen by nasal cannula, after which bowel motility with regularity was restored, obviating the need for colectomy...
  7. pmc Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials
    Lesley Ann Saketkoo
    Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA
    Thorax 69:428-36. 2014
    ..In the setting of connective tissue diseases (CTDs), some measures of ILD disease activity and severity may be confounded by non-pulmonary comorbidities...
  8. pmc Outcome Measures for Clinical Trials in Interstitial Lung Diseases
    Matthew R Lammi
    Louisiana State University Health Sciences Center, New Orleans, New Orleans, LA, USA New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center New Orleans, LA, USA
    Curr Respir Med Rev 11:163-174. 2015
    ..Candidate measures that were not selected as well as measures that were not available for examination at the time of the consensus process will also be discussed...
  9. doi request reprint Biologic therapies in the treatment of sarcoidosis
    Lesley Ann Saketkoo
    a New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, University Medical Center Comprehensive Pulmonary Hypertension Center, Tulane University Lung Center, New Orleans, LA, USA
    Expert Rev Clin Immunol 12:817-25. 2016
    ....
  10. pmc Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases
    Lesley Ann Saketkoo
    From the Louisiana State University LSU Scleroderma and Sarcoidosis Patient Care and Research Center, LSU Interstitial Lung Disease Program, LSU Health Sciences Center, New Orleans, Louisiana, USA University of Toronto, Interstitial Lung Disease Program, University Health Network Mount Sinai Hospital, Toronto, Ontario Faculty of Social Work, University of Manitoba, Winnipeg, Manitoba, Canada Louisiana Office of Public Health, Department of Health and Human Services, New Orleans, Louisiana Division of Rheumatology Internal Medicine, University of Michigan, Ann Arbor, Michigan Division of Immunology, Stanford University, Palo Alto, California and Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA
    J Rheumatol 41:792-8. 2014
    ....
  11. doi request reprint Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug
    Lesley Ann Saketkoo
    Arch Intern Med 168:1718-9. 2008